The founders of Escend have collective experience in cancer research, drug discovery, drug delivery technologies, and clinical drug development.  In addition, our skills involve intellectual property strategies around method of use and formulations to support  IND enabling studies. With our strong foundation, we exploit a number of approaches to identify small molecules with previous pre-clinical and clinical experience that can be exploited for development as novel therapeutics. 


Executive Members

Saira Bates, MBA, Co-founder & CEO

Dennis Brown, Ph.D., Co-founder



Scientific: Shaoguang Li, MD, PhD

Clinical: Jorge Cortes, MD

CMC: Mike Li, MS

Pharm/Tox: Sarath Kenekal, DVM, PhD, DABT, RAC